![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 405/12 | |
C07D 239/48 | |||
C07D 405/14 | |||
C07D 413/14 | |||
C07D 417/14 | |||
C07D 403/12 | |||
A61K 31/506 |
(11) | Number of the document | 1664035 |
(13) | Kind of document | T |
(96) | European patent application number | 04786952.4 |
Date of filing the European patent application | 2004-09-15 | |
(97) | Date of publication of the European application | 2006-06-07 |
(45) | Date of publication and mention of the grant of the patent | 2011-02-16 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2004/010348 |
Date | 2004-09-15 |
(87) | Number | WO 2005/026158 |
Date | 2005-03-24 |
(30) | Number | Date | Country code |
0321710 | 2003-09-16 | GB | |
0414440 | 2004-06-28 | GB |
(72) |
BAENTELI, Rolf, CH
BERNHARD, Marie, Claude, FR
BUEHLMAYER, Peter, CH
COOKE, Nigel, Graham, CH
DUTHALER, Rudolf, CH
HINTERDING, Klaus, DE
THOMA, Gebhard, DE
VAN EIS, Maurice, FR
VON MATT, Anette, CH
WALLISER, Louis, FR
ZENKE, Gerhard, DE
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT |
(54) | 2,4 DI(HETERO)-ARYLAMINO-PYRIMIDINE DERIVATIVES AS ZAP-70 AND/OR SYK INHIBITORS |
2,4 DI(HETERO)-ARYLAMINO-PYRIMIDINE DERIVATIVES AS ZAP-70 AND/OR SYK INHIBITORS |